Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Abnormal Liver Function Test

Recurrent Nasal Polyps Management – When to Refer

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

Vitiligo – Early Detection and Early Treatment

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis